Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Urticaria Market?

The market for urticaria has experienced swift expansion recently. The forecast predicts an increase from $4.03 billion in 2024 to $4.76 billion in 2025, this indicates a compounded annual growth rate (CAGR) of 18.1%. Key drivers of this growth in the historic period, include a higher occurrence of allergies, escalating cognizance of skin conditions, increased progress in immunology and biologics, a burgeoning requirement for antihistamines, and enhanced diagnostic methodologies.

The market size for urticaria is projected to experience a swifter upturn in the coming years, reaching an estimated $9.14 billion in 2029 thanks to a compound annual growth rate (CAGR) of 17.7%. The projected expansion throughout the forecast period could be due to a surge in chronic urticaria cases, a trend towards adopting biologic therapies, the injection of more funds into dermatology studies, increased access to cutting-edge allergy diagnostic equipment, and a rise in the creation of bespoke medicine. Key trends for the period forecast include diagnostic tools powered by AI, the creation of innovative biologics, enhancements in personalized immunotherapy, wearable devices designed for skin monitoring, and telemedicine for allergy treatment.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23554&type=smp

What Core Drivers Are Expected To Influence The Urticaria Market?

Growth in the urticaria market is anticipated to be propelled by the rising knowledge and treatment of skin diseases. The escalation in pollution levels leads to an influx in skin allergies and disorders, thus spurring the demand for improved understanding and innovative treatment options. Urticaria plays a crucial role in advancing skin disease comprehension and treatment, by underscoring immune system reactions, propelling research activities, augmenting diagnostic techniques, and facilitating targeted therapies. For instance, The Skin Cancer Foundation, a US-based nonprofit, in February 2024, reported that skin cancer affects 1 in 5 Americans by their 70s, with a fatal outcome every half hour in the U.S. Such alarming statistics highlight the immediate need for preventive strategies, as experiencing more than five sunburns doubles the odds of developing melanoma. Consequently, the rising awareness and approach towards skin diseases are fueling the expansion of the urticaria market.

What Are The Main Segment Classifications In The Urticaria Market?

The urticariamarket covered in this report is segmented –

1) By Type: Acute Urticaria; Chronic Urticaria

2) By Drug Class: Antihistamines; Anti-inflammation Medications; Antidepressants; Monoclonal Antibodies; Other Drug Classes

3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users

Subsegments:

1) By Acute Urticaria: Allergic Urticaria; Infectious Urticaria; Drug-Induced Urticaria; Contact Urticaria

2) By Chronic Urticaria: Chronic Spontaneous Urticaria (CSU); Chronic Inducible Urticaria (CIndU)

How Are Industry Trends Steering The Expansion Of The Urticaria Market?

Key players in the urticaria sector are prioritizing the development of innovative solutions such as mast cell inhibitor antibodies to create advanced therapeutic strategies for managing chronic spontaneous urticaria through mast cell activation targeting. A mast cell inhibitor antibody is a specialized monoclonal antibody that prevents the activation or degranulation of mast cells by targeting precise receptors or signaling routes, thus minimizing allergic responses, inflammation, and other mast cell-related disorders. For example, in May 2024, Allakos Inc., an American biotech firm, declared the start of a Phase 1 clinical trial for AK006, intended for the treatment of chronic spontaneous urticaria (CSU). This ground-breaking therapy aims at both IgE-dependent and IgE-independent mast cell activation routes, offering the possibility for wider efficacy in patients who are resistant to antihistamines or previous biologic therapies. By selectively blocking mast cell activity via the Siglec-6 receptor, AK006 strives to deliver a more inclusive and long-lasting solution for CSU management, signifying a substantial step forward in urticaria treatment and immunotherapy research.

Which Companies Are Contributing Significantly To The Urticaria Market Growth?

Major companies operating in the urticaria market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Ltd., Amneal Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals, Almirall S.A., Argenx SE, BioCryst Pharmaceuticals Inc., Pharvaris NV, Revolution Medicines Inc., Allakos.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/urticaria-global-market-report

Which Region Holds The Greatest Opportunity For Urticaria Market Expansion?

North America was the largest region in the urticaria market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urticaria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23554&type=smp

Browse Through More Reports Similar to the Global Urticaria Market 2025, By The Business Research Company

Transdermal Skin Patches Market 2025

https://www.thebusinessresearchcompany.com/report/transdermal-skin-patches-market

Natural Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report

Organic Skincare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/organic-skincare-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model